Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A decade of exploring the cancer epigenome — biological and translational implications
Stephen B. Baylin, Peter A. Jones
Nature reviews. Cancer (2011) Vol. 11, Iss. 10, pp. 726-734
Open Access | Times Cited: 2668

Showing 1-25 of 2668 citing articles:

Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
Nature Reviews Genetics (2012) Vol. 13, Iss. 7, pp. 484-492
Closed Access | Times Cited: 5433
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson, Tony Kouzarides
Cell (2012) Vol. 150, Iss. 1, pp. 12-27
Open Access | Times Cited: 2867
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Lovén, Heather A. Hoke, Charles Y. Lin, et al.
Cell (2013) Vol. 153, Iss. 2, pp. 320-334
Open Access | Times Cited: 2689
The molecular hallmarks of epigenetic control
C. David Allis, Thomas Jenuwein
Nature Reviews Genetics (2016) Vol. 17, Iss. 8, pp. 487-500
Closed Access | Times Cited: 2313
Evolution of the Cancer Stem Cell Model
Antonija Kreso, John E. Dick
Cell stem cell (2014) Vol. 14, Iss. 3, pp. 275-291
Open Access | Times Cited: 2039
Epigenetics and the environment: emerging patterns and implications
Robert Feil, Mario F. Fraga
Nature Reviews Genetics (2012) Vol. 13, Iss. 2, pp. 97-109
Closed Access | Times Cited: 1746
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli, Pamela L. Strissel, Alexis Desrichard, et al.
Cell (2015) Vol. 162, Iss. 5, pp. 974-986
Open Access | Times Cited: 1699
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo, Mark E. Dudley, Steven A. Rosenberg
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 269-281
Open Access | Times Cited: 1589
TET enzymes, TDG and the dynamics of DNA demethylation
Rahul M. Kohli, Yi Zhang
Nature (2013) Vol. 502, Iss. 7472, pp. 472-479
Open Access | Times Cited: 1486
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg, Ricky W. Johnstone
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 673-691
Closed Access | Times Cited: 1377
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William Flavahan, Yotam Drier, Brian B. Liau, et al.
Nature (2015) Vol. 529, Iss. 7584, pp. 110-114
Open Access | Times Cited: 1191
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng, Mia Spezia, Shifeng Huang, et al.
Genes & Diseases (2018) Vol. 5, Iss. 2, pp. 77-106
Open Access | Times Cited: 1174
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer, Imran S. Haque, Charles E. S. Roberts, et al.
Nature Reviews Genetics (2018) Vol. 20, Iss. 2, pp. 71-88
Closed Access | Times Cited: 1165
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
Nature Reviews Genetics (2017) Vol. 19, Iss. 2, pp. 81-92
Closed Access | Times Cited: 1164
Epigenetic plasticity and the hallmarks of cancer
William Flavahan, Elizabeth Gaskell, B Bernstein
Science (2017) Vol. 357, Iss. 6348
Open Access | Times Cited: 1150
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You, Peter A. Jones
Cancer Cell (2012) Vol. 22, Iss. 1, pp. 9-20
Open Access | Times Cited: 1096
Epigenetic Determinants of Cancer
Stephen B. Baylin, Peter A. Jones
Cold Spring Harbor Perspectives in Biology (2016) Vol. 8, Iss. 9, pp. a019505-a019505
Open Access | Times Cited: 1078
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee, Elena Piskounova, Sean J. Morrison
Cancer Cell (2012) Vol. 21, Iss. 3, pp. 283-296
Open Access | Times Cited: 1075
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang, Han Han, Daniel D. De Carvalho, et al.
Cancer Cell (2014) Vol. 26, Iss. 4, pp. 577-590
Open Access | Times Cited: 1055
Targeting the cancer epigenome for therapy
Peter A. Jones, Jean‐Pierre J. Issa, Stephen B. Baylin
Nature Reviews Genetics (2016) Vol. 17, Iss. 10, pp. 630-641
Closed Access | Times Cited: 1003
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions
Hao Wu, Yi Zhang
Cell (2014) Vol. 156, Iss. 1-2, pp. 45-68
Open Access | Times Cited: 997
Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility
Lovisa E. Reinius, Nathalie Acevedo, Maaike Joerink, et al.
PLoS ONE (2012) Vol. 7, Iss. 7, pp. e41361-e41361
Open Access | Times Cited: 977
Role of TET enzymes in DNA methylation, development, and cancer
K. Rasmussen, Kristian Helin
Genes & Development (2016) Vol. 30, Iss. 7, pp. 733-750
Open Access | Times Cited: 935
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng, He Cai, Manni Wang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 891
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin
Molecular Cell (2014) Vol. 54, Iss. 5, pp. 716-727
Open Access | Times Cited: 858
Page 1 - Next Page

Scroll to top